5 Hammerl JA, Beutlich J, Hertwig S et al. pSGI15, a small ColE-like qnrB19 plasmid of a Salmonella enterica serovar Typhimurium strain carrying Salmonella genomic island 1 (SGI1).
Sir, After a decade since discovery, a variety of qnr-type plasmidmediated quinolone resistance genes have been reported worldwide, especially in clinical isolates of Enterobacteriaceae. 1 Recently, we found that qnr genes (mostly qnrB) were highly prevalent among commensal enterobacteria from healthy children living in resource-limited urban settings of Latin America.
2 This unexpected finding could not be directly related with quinolone use, since these drugs are not prescribed in childhood. We then speculated that it could reflect a sustained adults-to-children transmission of enterobacteria within households (favoured by crowding and poor hygienic standards) and, possibly, a co-selection of the qnr-harbouring plasmids due to the presence of linked resistance determinants to antibiotics that are used in children. The latter explanation, however, was ruled out for the most prevalent qnr gene (qnrB19), whose dissemination was found to be related to a broad and interspecific diffusion of two small ColE-like plasmids harbouring this gene as the sole resistance determinant (plasmids pECC14-9 of 3.0 kb and pECY6-7 of 2.7 kb).
3 Similar small QnrB19-encoding ColE-like plasmids have recently also been identified in various Salmonella enterica serovars of human and animal origin, both in Latin America 4 (GenBank accession number GQ412195) and Europe, 5 underscoring their role in the international dissemination of qnrB19 in clinical and veterinary settings.
In this study, we investigated the presence of qnrB genes and qnrB-harbouring ColE-like plasmids in commensal enterobacteria from individuals of a very remote Chayahuita community of the Peruvian Amazonas (Angaiza, Alto Amazonas Province), which can be reached by the nearest urban area by a 13 h transfer (2 h drive on a track, 4 h motor-boat transfer and 7 h walk in the jungle). The community has a record of minimal exchanges with the exterior and minimal antibiotic exposure (not including quinolones, which are not available for clinical or veterinary use).
In December 2009, during a 2 day visit to Angaiza, faecal samples were obtained from 120 individuals (representing almost all members of the community). Full ethical clearance was obtained from the qualified local authorities (Comité Institucional de Ética of the Universidad Peruana Cayetano Heredia), and informed consent was obtained from all adult participants and from the parents or legal guardians of minors. Faecal swabs derived from each stool sample were stored in Amies transport medium (Oxoid, Milan, Italy) and then inoculated onto MacConkey agar plates supplemented with 0.12 mg/L ciprofloxacin (MCA-CIP). This concentration of ciprofloxacin was used since it was previously found to be appropriate for screening of faecal isolates carrying qnr genes.
2 Seventy samples yielded bacterial growth on MCA-CIP. Metagenomic DNA was extracted from the bacterial growth and was used as the template in PCR experiments aimed at detecting the presence of qnrB genes, as described previously.
2,3 qnrB genes were detected in 38 samples (32% of all screened individuals).
The nature of isolates carrying qnrB was investigated, as previously described. 2, 3 In brief, qnrB-positive samples were streaked onto MCA-CIP to yield isolated colonies and all colonies of different morphology were investigated for the presence of qnrB genes by PCR. qnrB-positive isolates were identified, tested for antibiotic susceptibility by the disc diffusion method and subjected to genotyping by random amplification of polymorphic DNA (RAPD). When two or more qnrB-positive isolates of the same species were observed in a sample, only one isolate was included in the data analysis. Overall, 34 isolates carrying qnrB were obtained from 29 of the 38 qnrB-positive samples (the lack of recovery of qnrB-positive isolates from 9 samples was probably due to their low frequency in such samples). The vast majority were Escherichia coli (n¼ 29, one from each sample), although qnrB was also detected in Escherichia fergusonii (n¼ 3), Enterobacter aerogenes (n¼ 1) and Kluyvera ascorbata (n¼ 1).
Most qnrB-positive isolates remained susceptible to ciprofloxacin (62% and 56%, according to CLSI and EUCAST interpretative criteria, respectively), while nalidixic acid non-susceptibility was common (97% and 79%, according to CLSI and EUCAST interpretative criteria, respectively) ( Table 1) . RAPD genotyping revealed clonal heterogeneity among qnrB-positive E. coli, with both intra-and inter-familial dissemination being observed for some clones (Table 1) .
All the 34 qnrB-positive isolates were investigated for the presence of the small QnrB19-encoding ColE-like plasmids pECC14-9 and pECY6-7, using a PCR mapping approach as described previously.
3 All but two qnrB-positive isolates were found to carry either pECC14-9-like or pECY6-7-like plasmids. In particular, pECC14-9-like plasmids were identified in 11 E. coli isolates (RAPD types A-C), while pECY6-7-like plasmids were identified in 16 E. coli isolates (RAPD types D-S) and in all the non-E. coli isolates (Table 1) .
In this study, we found that qnrB genes were prevalent in commensal enterobacteria from a very remote population of the Peruvian Amazonas, despite the high level of isolation and absence of antibiotic pressure. Furthermore, these genes were mostly carried by the same small ColE-like plasmids circulating in urban settings of the same geographical area, 3 and also detected in isolates of S. enterica from Latin America and Europe. 4, 5 These findings further underscore the high propensity for widespread and promiscuous dissemination of these small QnrB19-encoding ColE-like plasmids, even in the absence of evident selective pressure, and their potential role in the dissemination of qnrB resistance determinants. Further investigation of the biology of these plasmids and of their mechanisms of dissemination is warranted.
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None to declare. Sir, Salmonella genomic island 1 (SGI1) is a 43 kb genomic island containing a 13 kb multidrug resistance (MDR) region antibiotic resistance gene cluster initially identified in Salmonella enterica serovar Typhimurium definitive phage type (DT) 104 strains. Classically, the MDR region contains five antibiotic resistance genes, all of which are located within the boundaries of a complex class 1 integron, designated In104. 1 Over the past few years, SGI1 with variant antibiotic resistance gene clusters (termed variable SGI1) named SGI1-A to SGI1-T have been identified in several other Salmonella serotypes and also in Proteus mirabilis, 2 -4 suggesting possible horizontal gene transmission of the genetic element among microbes. However, it is worth noting that the direct association of the int2 gene, which is part of a retron sequence, with SGI1 has been reported only in S. enterica Typhimurium, while SGI1 is located between the thdF and yidY genes in other S. enterica serovars. 5 The integration of SGI1 into the P. mirabilis chromosome takes place between the thdF and hipB genes, according to the report by Boyd et al.
3 However, our overall understanding of the evolution of SGI1 and the potential risk of its dissemination among microbes remains very limited.
To reveal the genetic difference between SGI1 variants and the potential molecular events involved in the evolution and transmission of the MDR-encoding unit, based on an identical MDR profile to sulfamethoxazole, trimethoprim, tetracycline and erythromycin, a total of 23 P. mirabilis strains isolated in Guangzhou, China, were examined in this study. Seventeen of them originated from stools of 17 patients with diarrhoea in the First Affiliated Hospital of Jinan University from 2006 to 2008. The remaining six isolates were from 35 raw chicken meat samples purchased from two markets in 2009. PCR primers used in the screening for SGI1 are listed in Table S1 (available as Supplementary data at JAC Online). Eight P. mirabilis strains including three from chicken samples from the same seller in one of the markets and the other five from patients from 2006 to 2008 were found to harbour the dfrA5 cassette of class 1 integrons. To confirm the presence of SGI1, primer pairs corresponding to the left junction region (PmLJ1/LJ-R1) and right junction region (104-RJ/PmRJ1) of SGI1 in the P. mirabilis chromosome were used. PCR results were positive for the left junction of SGI1 with the thdF gene, but negative for the right junction with the hipB gene. The right junction region of SGI1 was then analysed by PCR with primers hipA-R1 (hipA specific) and MP-R1 (specific for the membrane protein PMI3124-encoding gene) targeting the two genes downstream of hipB of P. mirabilis HI4320. Positive results were found in all eight strains using primer pair 104-RJ and MP-R1. The PCR products were sequenced and the sequences flanking SGI1 were, with the exception of a few base changes, identical to part of the S044-and PMI3124-encoding genes. Thus, the eight P. mirabilis strains appeared to have SGI1 or variants integrated between thdF and the gene encoding PMI3124. Besides, the same integration site has been reported in a P. mirabilis isolate from France containing the SGI1-O variant.
6 Interestingly, the hipB and hipA genes were further screened using specific primers hipB-F1 and hipA-R1, and the results were negative. The results indicated that the eight P. mirabilis strains lacked the sequences of hipB and hipA genes (Figure 1) .
PCR mapping of the antibiotic resistance gene cluster was performed using primers described in Table S1 . PCR cloning and DNA sequencing revealed that all eight strains harboured a new variant designated SGI1-U. It contained the dfrA5 gene cassette within the integron structure. It is noteworthy that the dfrA5 cassette coding for trimethoprim resistance had not been reported in P. mirabilis before. Thus, the strains probably obtained the dfrA5 gene cassette from other microorganisms. The three strains from food and the five strains from patients had 100% identical SfiI and NotI PFGE patterns, suggesting that they might be clonally related.
In conclusion, for the first time, the new variant SGI1-U was identified in eight P. mirabilis clinical and food isolates from South China. It is also interesting that this is the first time the dfrA5 gene has been identified in P. mirabilis. In particular, the deletions of hipB and hipA genes found at the right junction region of SGI1-U showed that SGI1-U was located between the thdF gene and a gene encoding a membrane protein on the P. mirabilis chromosome.
Nucleotide sequence accession numbers
The right junction region of SGI1-U and the nucleotide sequence of the dfrA5 cassette have been deposited in the GenBank database under accession numbers HM747960 and HM747961, respectively.
